Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-15.22%
EBIT Growth (5y)
-215.10%
EBIT to Interest (avg)
-17.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.76
Sales to Capital Employed (avg)
0.69
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-30.38
EV to EBIT
-3.51
EV to EBITDA
-5.03
EV to Capital Employed
-22.38
EV to Sales
19.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET PROFIT(HY)
Higher at SEK -32.05 MM
RAW MATERIAL COST(Y)
Fallen by -98.28% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 12.28 times
-26What is not working for the Company
NET SALES(HY)
At SEK 0.54 MM has Grown at -95.89%
NET PROFIT(HY)
At SEK -32.05 MM has Grown at -130.7%
OPERATING CASH FLOW(Y)
Lowest at SEK -47.77 MM
INTEREST(HY)
At SEK 4.39 MM has Grown at 57.72%
DEBT-EQUITY RATIO
(HY)
Highest at 141.2 %
Here's what is working for Enorama Pharma AB
Net Profit
Higher at SEK -32.05 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
Inventory Turnover Ratio
Highest at 12.28 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -98.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Enorama Pharma AB
Net Sales
At SEK 0.54 MM has Grown at -95.89%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (SEK MM)
Net Profit
At SEK -32.05 MM has Grown at -130.7%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Operating Cash Flow
Lowest at SEK -47.77 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Interest
At SEK 4.39 MM has Grown at 57.72%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Debt-Equity Ratio
Highest at 141.2 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
